All News

Patients with diabetes are at risk for complications from vaccine-preventable diseases, making immunization especially critical.

In 2020, we know there will be a renewed focus on collaborating across health care specialties while reducing costs.

The approvals were granted to generic apixaban applications from Micro Labs Limited and Mylan Pharmaceuticals Inc.

Our most-read FDA approval articles from 2019. 

Walgreens, CVS Health, and Rite Aid are supporting the recently-launched “Ready, Set, PrEP” program.

Albertsons is expanding its partnership with Genomind to offer patients genetic testing to guide mental health medication management.

Many in community pharmacy worry that there are too many pharmacists for not enough jobs-whether it’s true or not is up for debate.

Simon Murray, MD, recently spent the day with Chris Castagna, RPh, an independent pharmacist.

Ongoing threats to the safety of intravenous (IV) drug delivery include drug shortages and lack of IV product standardization, according to an expert panel.

Invasive methods did not perform better than drug treatment in patients with stable ischemic heart disease

Ubrogepant (Ubrelvy) is the first oral calcitonin gene-related peptide receptor antagonist approved by the FDA for the acute treatment of migraine.

A new study of a vaccine used against a pneumonia-causing bacteria found that cases of severe pneumonia decreased by 35% among those children who had received the vaccine.

Fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo and AstraZeneca) is a new treatment option for patients with HER2-positive breast cancer who have progressed after 2 or more prior regimens.

Practical tips to help keep patients safe.

The proposed rule would allow for the importation of certain drugs from Canada.

As 2019 draws to a close, let’s look back at some of the top pharmacy news stories of the year.

Pharmacists can play an integral role in transitions-of-care for patients with chronic obstructive pulmonary disease (COPD) to prevent hospital readmissions.

Osteoarthritis is the most common type of arthritis, affecting nearly 54 million people.

Technology has long pushed the limits of the possible in pharmacy.

Offering immunizations is a smart business move, especially for independent pharmacies. 

Recent outbreaks in the United States are a reason to be concerned about vaccine misinformation getting to the public through social media. 

As participation in the 340B program becomes more of a political football especially in the upcoming 2020 election year, it is even more important to be mindful of access requirements and compliance tracking.

Every year, Drug Topics® asks pharmacists about their job experiences. These are the results from the 2019 annual pharmacy salary survey. 

20% subcutaneous immunoglobulin therapy.

A set of performance measures for older adults with type 2 diabetes at greater risk for hypoglycemia published by the Endocrine Society and Avalere Health.

A study examined influenza vaccination requirements for children who attend child care centers.

Officials with the FDA have approved a new indication and label expansion for icosapent ethyl (Vascepa, Amarin).

As hospital and health systems experienced nearly 20% growth in the specialty drug market in 2018, health systems continue to establish their own specialty pharmacies or expand their existing capabilities.